Document:

Exhibit 10.6

      

       

      

      ARTEMIS THERAPEUTICS, INC.

      

      

      __________, 2022

      

      

      Re: Warrant Exchange Agreement

      

      

      Dear _____:

      

                  Reference is made to that certain Warrant issued by Artemis Therapeutics, Inc., a Delaware corporation (the “Company”), to ___________ (the
        “Holder”), dated as of October 23, 2017 (the “Warrants”), attached
        hereto as Exhibit A, pursuant to which the Company granted the Holder a right to acquire up to an aggregate of _______ shares of common stock, par value $0.01 per share (the “Common Stock”), of the Company at a per share exercise price of $2.00 (subject to certain adjustments as provided in the Warrant). The Warrant was issued by the Company pursuant to that certain Securities Purchase Agreement dated October 23, 2017 by and among the Company and the Holder (the “Securities Purchase Agreement”). Capitalized terms not otherwise defined herein shall have the meanings given to them in the Securities Purchase Agreement and the Warrant.

      

        This letter agreement (the “Agreement”) is intended to document the agreement and understanding with respect to the circumstances under which (i) the
        Holder shall surrender the Warrant for cancellation, and (ii) the Company shall issue the Holder restricted shares of Common Stock as set forth herein.

      

        The Company and the Holder have agreed as follows:

      

      

      	1.	
              Surrender of the Warrant. Within 2 days from the date of this Agreement,
                the Holder shall surrender the Warrant for cancellation by delivery of the original Warrant (or a lost warrant affidavit with customary indemnity) to the Company at its office or to the Company’s counsel, Sullivan & Worcester, LLP, 1633
                Broadway, New York, NY 10019, Attention: Oded Har-Even, Esq. The Company and Holder further agrees that if the Warrant has been lost, mutilated or destroyed, an affidavit to such effect and indemnity reasonably acceptable to the Company,
                and the Warrant shall be deemed cancelled and of no further force or effect and shall thereafter represent only the right to receive the Shares even if the Holder fails to surrender the Warrant.

            

      

      

      	2.	
              Issuance of Replacement Shares. In connection with the surrender of the
                Warrant by the Holder, as set forth herein, and in order to induce the Holder to surrender the Warrant, upon delivery of the items pursuant to Section 1 hereof, the Company shall issue the Holder an aggregate of _______  shares of Common Stock (the “Replacement Shares”).

            

      

      

      	3.	
              Representations and Warranties of the Holder. The Holder shall be bound by
                and observe all the provisions and conditions of the Securities Purchase Agreement applicable to the Holder and hereby confirms the accuracy of the representations and warranties of the Holder set forth in Section 3.2 of the Securities
                Purchase Agreement in all material respects. In addition, the Holder represents and warrants that as of the date of this Agreement, the Holder has not sold the equity securities purchased with the Warrants pursuant to the Securities
                Purchase Agreement.

            

      

      

      
        
          

      

      
      	4.	
              Representations and Warranties of the Company. The Company hereby confirms
                the accuracy of the representations and warranties of the Company set forth in Section 3.1 of the Securities Purchase Agreement in all material respects except as such representations and warranties may have been changed, supplemented or
                amended by disclosure in SEC Reports filed subsequent to October 23, 2017.

            

      

      

      	5.	
              Governing Law and Jurisdiction. This Agreement and the rights and
                obligations of the parties hereunder shall be construed, enforced and interpreted according to the laws of the State of New York, without giving effect to its principles of conflict or choice of laws. Each party agrees that all legal
                proceedings concerning the interpretations and enforcement of this Agreement and the transaction contemplated hereunder shall be commenced exclusively in the state and federal courts sitting in the City of New York.  Each party hereby
                irrevocably submits to the exclusive jurisdiction of the courts of the State of New York located in New York County and the United States District Court for the Southern District of New York for the adjudication of any dispute hereunder or
                in connection herewith.

            

      

      

      	6.	
              Miscellaneous. This Agreement represents the entire agreement between the parties with respect to the subject matter hereof
                and may not be modified or amended except by a written instrument duly executed by the parties. This Agreement may be executed in any number of counterparts and by different parties hereto in separate counterparts, each of which when so
                executed and delivered shall be deemed to be an original and when a counterpart has been executed by each of the parties hereto, all of the counterparts, when taken together, shall constitute one and the same agreement. If one or more
                provisions of this Agreement are held to be unenforceable under applicable law, such provision shall be excluded from this Agreement and the balance of the Agreement shall be interpreted as if such provision were so excluded and shall be
                enforceable in accordance with its terms.

            

      

      

      [signature page follows]

      

      

      
        2

        
          

      

      Please execute this Agreement in the space provided below in order to evidence your agreement with the terms hereof.

      

        Sincerely,

        

        ARTEMIS THERAPEUTICS, INC.

      

          By:_____________________

          Name:

          Title:

          

      

      Date: ________________

        

        ACCEPTED AND AGREED:

        

        HOLDER:

      

      

      ________________

      

        By:_________________

        Name:

        Title:

        

        Date: ________________

      

      

      
        3

        
          

      

      EXHIBIT A

      

      

      Warrant

      

      

      See attached.

      

      

      

      

      

        

      

    

  

  4Exhibit 10.7

      

       

      

      DEBT FORGIVENESS AGREEMENT

      

      

      THIS DEBT
          FORGIVENESS AGREEMENT (this “Agreement”) is made and entered into and effective as of this __th day of _____, 2022 by and between Artemis Therapeutics, Inc., a Delaware corporation (“Artemis”),
        and _____________ (the “Lender”).

      

      

      WHEREAS, on
        the terms and subject to the conditions set forth in this Agreement, and as a condition to that certain Share Exchange Agreement by and between Artemis and MANUKA Ltd., a limited liability company organized under the laws of the State of Israel,
        dated on or about a date even herewith (the “Share Exchange Agreement”), the Lender agrees to waive, cancel and forgive certain indebtedness
        previously advanced by Lender to Artemis;

      

      

      NOW, THEREFORE,
        in consideration of the foregoing premises, and the agreements set forth herein, and for other good and valuable consideration, the receipt and sufficiency of which the parties hereby acknowledge, the parties hereto hereby agree as follows:

      

      

      	1.	
              Forgiven Debt. The Lender hereby waives, cancels and forgives payment by
                Artemis of aggregate of $__ of indebtedness previously advanced by the Lender to Artemis and currently owed (the “Forgiven Debt”) in
                consideration of, and conditioned upon the Lender’s receipt of an aggregate of ______ shares of Artemis’ common stock (the “Debt Forgiveness
                  Shares”). It is acknowledged and agreed that the Forgiven Debt is being waived, cancelled and forgiven by the Lender in its entirety in consideration of the issuance of the Debt Forgiveness Shares.

            

      

      

      	2.	
              Issuance of the Debt Forgiveness Shares. Artemis hereby agrees to issue to
                the Lender the Debt Forgiveness Shares in consideration of the waiver, cancellation and forgiveness of the Forgiven Debt, immediately upon the consummation of the Share Exchange Agreement, but in any event not later than two (2) business
                days thereafter. Upon the issuance of the Debt Forgiveness Shares, the Forgiven Debt shall be deemed to be paid in full, released and discharged, all without any further action being required of the Lender or Artemis.

            

      

      

      	3.	
              Representation of No Other Debt. The Lender represents and warrants that
                Artemis does not have any other debts, liabilities or obligations to pay any amounts to the Lender other than the Forgiven Debt, all of which shall be waived, cancelled and forgiven as set forth herein.

            

      

      

      	4.	
              Effectiveness of Agreement. This Agreement shall only be effective upon the
                consummation of the transaction contemplated by the Share Exchange Agreement. If the transactions contemplated by the Share Exchange Agreement shall not be consummated, this Agreement and the provisions thereof (even though fully executed)
                shall be void and of no force and effect whatsoever.

            

      

      

      	5.	
              Successors and Assigns. This Agreement shall be binding upon and inure to
                the benefit of the parties and their successors and permitted assigns. The parties may not assign this Agreement or any rights or obligations hereunder without the prior written consent.

            

      

      

      	6.	
              No Third-Party Beneficiaries. This Agreement is intended for the benefit of
                the parties hereto and their respective successors and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other person.

            

      

      

      	7.	
              Governing Law. All questions concerning the construction, validity,
                enforcement and interpretation of this Agreement shall be governed by and construed and enforced in accordance with the internal laws of the State of Delaware, without regard to the principles of conflicts of law thereof.

            

      

      

      	8.	
              Entire Agreement. This Agreement constitutes the entire agreement between
                the parties with respect to the subject matter hereof and supersedes any prior understanding or representation of any kind preceding the date of this Agreement. This Agreement may only be amended or modified in a signed by both parties
                hereto.

            

      

      

      	9.	
              Execution. This Agreement may be executed in two or more counterparts, all
                of which when taken together shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to each other party, it being understood that the parties need not sign
                the same counterpart. In the event that any signature is delivered by e-mail delivery of a “.pdf” format data file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is
                executed) with the same force and effect as if such “.pdf” signature page were an original thereof.

            

      

      

      
        
          

      

      	10.	
              Arm’s Length Transaction. The parties hereto have entered into this
                Agreement and the transactions contemplated hereby on an arms-length basis.

            

      

      

      	11.	
              Release. The Lender, singly, and for each present and former, direct and/or
                indirect, parents, subsidiaries, affiliates, attorneys, agents, representatives, employees, consultants, brokers, officers, directors, equity and/or debt holders, managers, members, successors, predecessors, heirs and assigns (collectively
                the “Lender Releasors”), hereby expressly and irrevocably release, waive and forever discharge and hold harmless each of the Company and
                each of its present and former, direct and/or indirect, parents, subsidiaries, affiliates, attorneys, agents, representatives, employees, consultants, brokers, officers, directors, equity and/or debt holders, managers, members, successors,
                predecessors, and assigns (collectively, the “Lender Released Parties”) regarding the Forgiven Debt from any and all actions, causes of
                action, suits, losses, liabilities, rights, debts, dues, sums of money, accounts, reckonings, obligations, costs, expenses, liens, bonds, bills, specialties, covenants, contracts, controversies, agreements, promises, variances, trespasses,
                damages, judgments, extents, executions, claims, and demands, of every kind and nature whatsoever, whether now known or unknown, suspected or unsuspected, foreseen or unforeseen, matured or unmatured, suspected or unsuspected, in law,
                admiralty or equity, which any of the Lender Releasors ever had, now have, or hereafter can, shall, or may have against any of the Lender Released Parties from the beginning of time through and including the date hereof.

            

      

      

      	12.	
              Counterparts. This Agreement may be executed in two or more identical
                counterparts, all of which shall be considered one and the same agreement and shall become effective when such counterparts have been signed by each party and delivered to the other parties; provided that a facsimile signature shall be
                considered due execution and shall be binding upon the signatory thereto with the same force and effect as if the signature were an original, not a facsimile, signature.

            

      

      

      [Signatures on following page.]

      

      

      
        
          

      

      IN WITNESS WHEREOF,
        the parties hereto have caused this Debt Forgiveness Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.

      

      

      	 	
              ARTEMIS THERAPEUTICS, INC.

            
	 	 	 
	 	
              By:

            	 
	 	 	
              Name:

            	 
	 	 	
              Title:

            	 
	 	 
	 	
              [LENDER]

               

            
	 	
              By:

            	 
	 	 	
              Name:

            	 
	 	 	
              Title:

            	 

      

      

      [Signature page to Debt Forgiveness Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00346-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00346-of-00352.parquet"}]]